{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-113893","form_type":"8-K","ticker":"PROK","cik":"0001850270","company_name":"PROKIDNEY CORP.","filed_at":"2026-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.532959+00:00","generated_at":"2026-05-15T09:55:55.834278+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ProKidney reports 2025 net loss $151.6M, cash $270M; Phase 3 PROACT 1 on track for mid-2026 enrollment","bullets":["Net loss $151.6M in 2025 vs $163.3M in 2024; no revenue as pre-revenue cell therapy company.","Cash and marketable securities $270.0M at Dec 31, 2025, down from $358.3M; runway into mid-2027.","Phase 3 PROACT 1 enrollment for accelerated approval (n~360) on track for mid-2026; top-line eGFR slope data Q2 2027.","FDA confirmed in July 2025 Type B meeting that eGFR slope can serve as surrogate endpoint for accelerated approval.","Positive Phase 2 REGEN-007 results presented at ASN Kidney Week 2025 and published in CJASN."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-113893","json":"https://secwatch.observer/filing/0001193125-26-113893.json","markdown":"https://secwatch.observer/filing/0001193125-26-113893.md","text":"https://secwatch.observer/filing/0001193125-26-113893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526113893/0001193125-26-113893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526113893/prok-20260318.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:55:55.834278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}